Cellectar Biosciences, Inc. Current Federal Tax Expense (Benefit)
Cellectar Biosciences, Inc. (CLRB) reported Current Federal Tax Expense (Benefit) of $0 for the 12-month period ending 2019-12-31, per its 10-K filed 2020-03-09.
Discontinued › Expense Statement › Income Tax
us-gaap:CurrentFederalTaxExpenseBenefit · last filed 2020-03-09
- Cellectar Biosciences, Inc. current federal tax expense (benefit) for fiscal 2019 was $0.00.
- Cellectar Biosciences, Inc. current federal tax expense (benefit) for fiscal 2018 was $0.00.
- Cellectar Biosciences, Inc. current federal tax expense (benefit) for fiscal 2017 was $0.00.
- Cellectar Biosciences, Inc. current federal tax expense (benefit) for fiscal 2016 was $0.00.
| Period end | Current Federal Tax Expense (Benefit) 12 month |
|---|---|
| 2019-12-31 | $0.00 10-K · filed 2020-03-09 |
| 2018-12-31 | $0.00 10-K · filed 2020-03-09 |
| 2017-12-31 | $0.00 10-K · filed 2019-02-26 |
| 2016-12-31 | $0.00 10-K · filed 2018-03-21 |
| 2015-12-31 | $0.00 10-K · filed 2017-03-15 |
| 2014-12-31 | $0.00 10-K/A · filed 2016-10-20 |
| 2013-12-31 | $0.00 10-K · filed 2015-05-20 |
| 2012-12-31 | $0.00 10-K · filed 2014-03-19 |
| 2011-12-31 | $0.00 10-K · filed 2013-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |